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Abstract
Introduction Cystinosis is an autosomal recessive disorder
leading to intralysosomal cystine accumulation in various
tissues. It causes renal Fanconi syndrome and end stage
renal failure around the age of 10 years if not treated with
cysteamine. Children with cystinosis seem to have a normal
intelligence but frequently show learning difficulties. These
problems may be due to specific neurocognitive deficits
rather than impaired renal function. Whether cysteamine
treatment can improve cognitive functioning of cystinosis
patients is thus far unknown. We aim to analyze neuro-
cognitive functioning of school-aged cystinosis patients
treated with cysteamine in order to identify specific deficits
that can lead to learning difficulties.
Patients and methods Fourteen Dutch and Belgian school-
aged cystinosis patients were included. Glomerular filtration
rate was estimated using the Schwartz formula. Children were
tested for general intelligence, visual-motor integration,
inhibition, interference, sustained attention, accuracy, plan-
ning, visual memory, processing speed, motor planning,
fluencyandspeed,andbehaviouralandemotionalfunctioning
using standardized methods.
Results Glomerular filtration rate ranged from 22 to
120 ml min
−1 1.73 m
−2. Median full-scale intelligence
was below the average of a normal population (87, range
60–132), with a discrepancy between verbal (median 95,
range 60–125) and performance (median 87, range 65–
130) intelligence. Over 50% of the patients scored poorly
on visual-motor integration, sustained attention, visual
memory, planning, or motor speed. The other tested areas
showed no differences between patients’ and normal
values.
Conclusion Neurocognitive diagnostics are indicated in
cystinosis patients. Early recognition of specific deficits
and supervision from special education services might
reduce learning difficulties and improve school careers.
Abbreviations
GFR Glomerular filtration rate
IQ Intelligence quotient
VMI Visual motor integration
CBCL Child behavior checklist
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Cystinosis is a rare autosomal recessive disorder caused
by mutations in the CTNS gene, encoding the lysosomal
cystine carrier cystinosin. This results in intralysosomal
a c c u m u l a t i o no ft h ea m i n oa c i dc y s t i n e( T o w ne ta l .1998).
T h em o s tf r e q u e n ta n ds e v e re infantile form has an
incidence of 1 case in every 100,000 to 200,000 live
births. Children present with renal Fanconi syndrome,
mostly during the first year of life. This generalized
proximal tubular damage progresses towards end stage
renal disease around the age of 10 years. Extra-renal
organs are also affected, including eyes, endocrine organs,
muscles, and central nervous system. Cystinosis is treated
by administration of the cystine-depleting agent cyste-
amine, which slows down the progression of renal failure
and protects extra-renal organs (Gahl et al. 2002).
Previously it was believed that since children with
cystinosis have a normal intelligence, no learning difficul-
ties should be expected. Moreover, poor school results were
often explained by renal disease or seen as a consequence
of a chronic illness and its treatment. In 1988, however, it
was demonstrated that cystinosis patients have neuro-
cognitive impairments that cannot be attributed to their
decreased renal function (Trauner et al. 1988). Despite a
normal intelligence, deficits in visual information process-
ing and tactile recognition processing have been reported.
As a result, poor school performances, in particular for
spelling and arithmetic, have been found (Ballantyne et al.
1997; Colah and Trauner 1997; Spilkin et al. 2007;
Williams et al. 1994; Wolff et al. 1982).
The aim of this study was to analyze neurocognitive
functioning in Dutch and Belgian school-aged cystinosis
patients treated with cysteamine starting from an early
age in order to identify specific deficits that might lead
to learning difficulties and to evaluate the influence of
cysteamine treatment. Furthermore, we analyzed the
effect of different CTNS mutations on neurocognitive
functioning.
Patients and methods
Fourteen school-aged cystinosis patients (age 6–17 years),
treated in three Dutch and two Belgian hospitals, were
included. Cystinosis was diagnosed at a mean age of 1 year
and 10 months, and cysteamine treatment was started
immediately thereafter and monitored by measuring white
blood cell (WBC) cystine levels every 2–4 months. The
diagnosis was confirmed by mutational analysis of the
CTNS gene in 13/14 patients. “Whole life” mean WBC
cystine levels were calculated from all measurements after
the onset of cysteamine treatment. The glomerular filtration
rate (GFR) at the moment of testing was estimated using
the Schwartz formula (Schwartz et al. 2009). Patients were
scheduled for neurocognitive assessment after written
informed consent was obtained from parent(s) and patients
≥12 years of age. A standard test battery was completed by
all patients. These tests were administered by a trained
psychology assistant, who was supervised by a research
psychologist. The study was approved by the institutional
review board of the Radboud University Medical Centre.
General intelligence
WISC-III
The Wechsler Intelligence Scale for Children, 3rd edition
(WISC-III) is a standardized method to test the intelligence
quotient (IQ) in children 6–16 years of age (Kort et al.
2002;W e c h s l e r1991). Patient 8 (17.4 years of age)
completed the Wechsler Adult Intelligence Scale (WAIS).
Three general measures were derived: full-scale IQ, verbal
IQ, and performance IQ.
Neurocognitive function
VMI
The Developmental Test of Visual-Motor Integration (VMI)
measures visual-motor integration skills, indicated by the
ability to copy increasingly complex geometric forms
(Beery 1997).
Stroop Color-Word Interference Test
The Stroop Color-Word Interference Test measures inhibi-
tion and interference (e.g., the ability to suppress a habitual
response in support of an unusual one) (Hammes 1978). It
is divided into word reading (reading color names printed
in black) and color naming (naming the print colors of
colored bars and naming the print colors of color names
when both are not the same). The latter measures the ability
to say the print color while suppressing the response to say
the color name, which is an interference test. Although this
test was originally developed for adults, standardized age
norms (7–12 years) for the Dutch population were available
and used. The test was not performed in patient 2, since
she was <7 years of age and in patients 4 and 8, since they
were >12 years of age.
Bourdon-Vos Test
The Bourdon-Vos Test measures sustained attention and
accuracy (Vos 1998). Children had to cross out all groups
of four dots on a page filled with groups of three, four, and
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and evaluated. Patient 13 was too tired to complete the test.
Rey-Osterrieth Complex Figure
Rey’s figure was administered to measure planning
(organization) and visual memory (Bernstein and Waber
1996) .C h i l d r e nh a dt oc o p yac o m p l e xf i g u r ea n dd r a wi t
from memory immediately thereafter (immediate recall)
and after a delay of 20 min (delayed recall). Since the test
has a norm only for children up to 14 years of age, it was
not performed in patients 4 and 8.
Computerized drawing task
A computerized drawing task was administered to evaluate
processing speed, motor planning, motor fluency, and motor
speed (Schoemaker et al. 1994). Drawing movements were
digitally recorded by a digitizing tablet and a wireless electronic
pen. Processing speed was indicated by mean reaction time,
motor planning by mean duration of pauses between small and
large elements, motor fluency by mean number of velocity
peaks, and motor speed by mean drawing speed (cm/s).
Behavioral and emotional functioning
CBCL
The Child Behavior Checklist (CBCL) is used to recognize
problemsofbehavioralandemotionalfunctioning(Achenbach
1991). Three parallel versions of the Dutch CBCL were
administered: a parent’s version, a patient’s version for
children ≥12 years of age, and a teacher’s version (Verhulst
et al. 1996, 1997a, b). Scores indicating internalizing,
externalizing, and total problems were derived.
Statistical analysis
Correlations between full-scale, verbal, and performance
IQ and GFR and between full-scale, verbal, and performance
IQ and “whole life” WBC cystine levels were estimated
using the Spearman rank correlation method. The general
intelligence measures of patients having a homozygous
57 kb deletion of the CTNS gene were compared with
those of patients with other mutations using the Mann-
Whitney U tests. Values were considered statistically
significant at P<0.05.
Results
Data on GFR, WBC cystine levels, CTNS gene mutations,
and educational levels of the parents are shown in Table 1.
Eight patients were homozygous for the large 57 kb
deletion in the CTNS gene, and five patients were
heterozygous and had the 57 kb deletion combined with
another mutation; DNA analysis was not performed in
patient 13. GFR ranged from 22 to 120 (normal ≥90) ml
min
−1 1.73 m
−2, seven patients had a decreased GFR of
<90 ml min
−1 1.73 m
−2, and patient 4 had a functioning
renal graft. Mean WBC cystine levels were within the range
of healthy carriers (0.26–0.86 nmol half-cystine/mg pro-
tein) in 5/14 patients, indicating adequate cysteamine
treatment (Table 1). Results of the neurocognitive tests are
shown in Table 2. Scores were defined as average, poor, or
low according to the instructions in the test manuals. In all
tests except for Rey’s figure, a score of 1 standard deviation
(SD) or more above or below the average was considered to
be significant. In Rey’s figure, scores were qualified as poor
if below or equal to the 10th percentile and good if above or
equal to the 90th percentile. The WISC-III, WAIS, and
VMI have an average score of 100, with an SD of 15.
General intelligence
Median full-scale IQ was 87 (range 60–132), median verbal
IQ 87 (range 60–125), and median performance IQ 95
(range 65–130). Five patients (36%) scored ≥1 SD below
the average for full-scale IQ. In five patients (36%), the
verbal IQ was ≥1 SD higher than the performance IQ, none
of the patients had a significantly better performance IQ
compared to the verbal IQ.
Neurocognitive functions
All 14 children completed the VMI. Seven children (50%)
had a poor performance (≤85 points), and none had a good
performance (≥115 points) on this test.
TheStroopColor-WordInterferenceTestwasperformedin
11/14patientsandshowednoabnormalities:5children(45%)
had an average performance, 3 children (27%) had a poor
performance, and 3 children (27%) had a good performance.
The Bourdon-Vos Test was performed in 13/14 patients.
Only four patients (31%) showed a normal sustained
attention, while the other nine patients (69%) showed a
delayed sustained attention. There were no evident problems
in accuracy: six children (46%) had a good performance, five
children (38%) had a poor performance.
The Rey-Osterrieth Complex Figure was completed by 12/
14 children. Four patients (33%) had a score of poor on
planning (organization), only one patient (8%) had a score of
good on planning items. Three patients (25%) had a score of
pooronvisualmemory,nonehada score ofgoodonthisitem.
The computerized drawing task was completed by all 14
children. Two patients (14%) had a good score on
processing speed, and four patients (29%) had a poor score
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planning, whereas eight patients (57%) had a poor score on
this measure. Motor fluency and motor speed showed no
evident problems: three patients (21%) showed a good
score and two patients (14%) showed a poor score on motor
fluency, while two patients (14%) showed a good score and
three patients (21%) showed a poor score on motor speed.
Behavioral and emotional functioning
Teachers reported poor school performances in two or more
areas in seven patients (50%, data not shown). The reported
problem areas included arithmetic, spelling, reading com-
prehension, and knowledge of the world. All seven of these
patients (patients 01, 03, 07, 08, 09, 10, and 14) had a risk
profile for neurocognitive dysfunction, e.g., they showed a
low general intelligence level or a discrepancy between
verbal and performance IQ and/or a poor performance on
neurocognitive tasks. No significant behavioral or emotional
problems were reported by parents or patients.
Statistical analysis
Wefoundnosignificantcorrelationbetweenfull-scale,verbal,
and performance IQ and GFR. Unexpectedly, a significant
positive correlation was found between mean “whole-life”
WBC cystine levels and full-scale IQ (R=0.68, P=0.007),
verbal IQ (R=0.57,P=0.033), and performance IQ (R=0.73,
P=0.003). Full-scale, verbal, and performance IQ were not
different between patients having the homozygous 57 kb
deletion and patients with other mutations.
Discussion
This study aimed at examining neurocognitive functioning
in school-aged cystinosis patients treated with cysteamine
starting at an early age in order to find evidence for
clinically observed learning difficulties in this patient
group. We found a poorer performance on visual-motor
integration (VMI), sustained attention (Bourdon-Vos Test),
visual memory (Rey’s figure), planning (Rey’sf i g u r e ,
drawing task), and motor speed (drawing task). The finding
of a full-scale IQ just below the average with a relative
good verbal IQ and poor performance IQ combined with
poor executive functions is in line with the results of other
international studies on neurocognitive functioning in
children with cystinosis (Ballantyne et al. 1997; Colah
and Trauner 1997; Spilkin et al. 2007, 2009; Ulmer et al.
2009; Williams et al. 1994; Wolff et al. 1982).
Interestingly, teachers reported more school problems
than parents and patients ≥12 years (CBCL). It should be
noted however that scores on the CBCL are slightly
distorted in pediatric populations (Perrin et al. 1991). This
Table 1 Clinical data on the patients and educational levels of the parents
Patient Age
(years)
Sex Age at onset
of cysteamine
therapy (years)
DNA analysis
of CTNS gene
Renal
status
GFR (ml min
−1
1.73m
−2)
Mean (SD) cystine
levels
a (nmol half-
cystine/mg protein)
Educational
background
father
Educational
background
mother
01 10.0 F 1.2 hom 57 kb del NK 22 0.98 (0.46) U U
02 6.3 F 1.3 57 kb del/c.del18
_21GACT
NK 86 3.10 (1.36) V V
03 11.1 F 1.10 hom 57 kb del NK 48 0.74 (0.64) V LS
04 15.5 F 1.8 hom 57 kb del Tx 72 0.92 (0.52) HV HV
05 10.7 M 9.0 57 kb del/c.198
_218del21
NK 113 1.10 (0.36) V HS
06 8.4 M 1.3 hom 57 kb del NK 84 0.86 (0.54) V HS
07 9.2 M 0.9 hom 57 kb del NK 100 0.96 (0.52) V LS
08 17.4 M 0.6 hom 57 kb del NK 57 0.84 (0.40) HV V
09 11.8 F 1.4 57 kb del/c.665 A>G NK 120 0.64 (0.34) V V
10 11.8 F 1.4 57 kb del/c.665 A>G NK 120 0.60 (0.34) V V
11 11.3 M 2.8 57 kb del/c.926dup NK 89 2.03 (1.28) V HV
12 7.4 M 0.10 hom 57 kb del NK 112 4.75 (2.62) U U
13 8.1 M 1.6 Not done NK 118 1.56 (0.68) V LS
14 8.6 M 0.10 hom 57 kb del NK 103 0.96 (0.74) LV LS
NK Native kidney, Tx renal transplantation, V vocational education, LV lower vocational education, HV higher vocational education, LS lower
secondary education, HS higher secondary education, U university education
aNormal values for healthy carriers: 0.26–0.86 nmol half-cystine/mg protein
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J Inherit Metab Dis (2010) 33:787–793 791is due to the fact that children suffering from a somatic
disorder show an increased risk for overall adjustment
problems, internalizing and (to a lesser extent) externalizing
symptoms. Therefore, they are more likely to show higher
scores on the scales of somatic complaints and internalizing
problems when compared to their healthy peers (Lavigne
and Faier-Routman 1992). It is known that patients over
12 years of age do not seem to recognize their emotional
and learning difficulties (Delgado et al. 2005;G i p s o ne ta l .
2004), and it might be suggested that parents do not expect
their children to have major school problems, since they
seem to have a normal intelligence and in particular normal
or even above normal verbal levels. A study using the CBCL
conducted in 2005 on behavioral problems in children with
cystinosis revealed more social problems in cystinosis
patients compared to patients with another chronic disease
(cystic fibrosis) and compared to healthy control subjects.
However, in that study only the patients and their parents,
and not the teachers, completed the checklists (Delgado et al.
2005). In our study, such behavioral problems were not
reported.
A limitation of this study is the small study population,
since cystinosis is a very rare disorder. We also found a
broad heterogeneity in terms of general intelligence. On the
other hand, the strength of this work lays in the broad pallet
of standardized tests, which were adequately administered
by a trained team of psychologists.
Pathogenesis of neurocognitive disturbances in cystinosis
The pathogenesis of brain involvement in cystinosis remains
unclear. Thus far, three hypotheses have been postulated.
These include progressive accumulation of cystine in brain
cells (in particular oligodendrocytes), progressive develop-
ment of intracranial microvascular disease, and alterations of
the blood-brain barrier leading to cystine deposits within
cerebral pericytes, thus making them unable to prevent
circulating toxins from entering the central nervous system
(Vogel et al. 1990).
A study performed on ctns
-/- knockout mice showed
spatial short-term memory impairments, comparable to the
cognitive anomalies found in cystinosis patients. The highest
cystine levels were found in the hippocampus, cerebellum,
and brainstem, respectively (Maurice et al. 2009). In human
cystinosis patients, cystine accumulates in all parts of the
brain, especially in the basal ganglia (Jonas et al. 1987).
Whether cysteamine therapy is able to influence learning
difficulties remains unclear. Our study failed to demonstrate
a positive effect of cysteamine therapy, evaluated by “whole-
life” WBC cystine levels, on neurocognitive functioning. In
line with our results, it should be noted that the study by
Wolff et al. conducted on patients not treated with
cysteamine showed a similar pattern of normal general
intelligence with relatively poor scores for performance IQ
and relative good scores for verbal IQ (Wolff et al. 1982).
Interestingly,wefoundapositivecorrelationbetweenWBC
cystine levels and full-scale, verbal, and performance IQ
results.Thisunexpectedobservationmightbeduetounknown
side effects of cysteamine on brain function. Cysteamine is
suggested to cross the blood-brain barrier as mixed disulfide
withcysteineandisreducedincerebrotofree cysteamine.The
administration of supraclincal doses of cysteamine (250 mg/
kg) to rats showed a remarkable increase in cerebral and
cerebellar levelsof methionine,anda dropincerebral levelsof
cysteine and an anti-oxidant compound, S-(2-aminoethyl)-L-
cysteine ketimine decarboxylated dimer (AECK-DD), proba-
blyduetotheoxidativeeffectofcysteamine(Pintoetal.2009).
It cannot be ruled out that the administration of high
cysteamine doses might have a detrimental effect on the
brain. Studies of cysteamine metabolites in the spinal fluid of
cystinosis patients might help to clarify pathways involved in
cerebral cysteamine metabolism in humans and to identify
eventual markers of cysteamine-induced damage. Unfortu-
nately, we could not determine “whole-life” cysteamine dose
in our patients because it was not always correctly noted in
the patient’s records, and we had no information about
compliance. In an earlier study, a negative association was
found between the variance in cystine levels and performance
IQ (Bava et al. 2010); these findings should be further
examined in larger patient populations and in ctns
-/- mice
treated with cysteamine.
In our study, patients with the homozygous 57 kb deletion
had a general intelligence comparable to those with heterozy-
gous mutations. This suggests that the absence of the CARKL
gene, which is another gene removed in patients with
homozygous 57 kb deletion (Wamelink et al. 2008), does
not contribute to the cerebral dysfunction of cystinosis
patients.
Conclusion
Neurocognitive diagnostics aimed at visual-motor integra-
tion, visual memory, planning, sustained attention, and
motor speed are indicated in all cystinosis patients from the
age of 7–8 years. Deficits in these fields can lead to
learning difficulties in reading, spelling, and arithmetic. For
instance, poor visual motor integration, motor speed, and
sustained attention may prevent the child from recognizing
letter forms, recalling and writing them, and from meeting
the time constraints often involved in school assignments.
Early neuropsychological diagnostics can contribute to
early recognition from special education services, which
might reduce the development of these learning problems
and result into targeted remedial teaching. Parents and
teachers should be informed that possible deficits or “minor
symptoms” might not be attributed to the general effects of
792 J Inherit Metab Dis (2010) 33:787–793having a chronic disease. Further research on the etiology
of specific deficits of neurocognitive functioning in school-
aged cystinosis patients is recommended.
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